Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.038
-0.262 (-7.93%)
Nov 5, 2026, 12:54 PM EST - Market open
Indaptus Therapeutics Employees
Indaptus Therapeutics had 5 employees as of December 31, 2025. The number of employees decreased by 2 or 28.57% compared to the previous year. That makes Indaptus Therapeutics the 41,764th largest employer in the world and 6,506th in the United States.
Employees
5
Change (1Y)
-2
Growth (1Y)
-28.57%
Revenue / Employee
n/a
Profits / Employee
-$3,084,700
Market Cap
466.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -2 | -28.57% | 5 | 0 |
| Dec 31, 2024 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 7 | 0 |
| Dec 31, 2022 | 6 | 1 | 20.00% | 6 | 0 |
| Dec 31, 2021 | 5 | 3 | 150.00% | 5 | 0 |
| Jun 30, 2021 | 5 | - | - | 5 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Valneva SE | 620 |
| REGENXBIO | 371 |
| Arvinas | 246 |
| Puma Biotechnology | 179 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
| Surrozen | 44 |
INDP News
- 2 months ago - Indaptus Therapeutics files to sell 59M shares of common stock for holders - TheFly
- 2 months ago - Indaptus Therapeutics Registration statement: Registration filing - Filings
- 2 months ago - Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Indaptus Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Indaptus Therapeutics Earnings release: Q2 2026 - Filings
- 3 months ago - Indaptus Therapeutics Proxy statement: Proxy filing - Filings
- 4 months ago - Indaptus Therapeutics files to sell 18.86M shares of common stock for holders - TheFly
- 4 months ago - Indaptus Therapeutics Registration statement: Registration filing - Filings